Log in

Relevant bibliographies by topics / Drugs / Journal articles

Journal articles on the topic 'Drugs'

To see the other types of publications on this topic, follow the link: Drugs.

Author: Grafiati

Published: 4 June 2021

Last updated: 31 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Khanapure, Amol, Pem Chuki, and Avinash De Sousa. "Drug Repositioning : Old Drugs For New Indications." Indian Journal of Applied Research 4, no. 8 (October 1, 2011): 462–66. http://dx.doi.org/10.15373/2249555x/august2014/119.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Bocharova, Inna Anatolevna, Vadim Agadzhanov, and Vadim Sagalaev. "Drug addiction. Drugs and their effects on man." Vestnik Volgogradskogo Gosudarstvennogo Universiteta. Serija 11. Estestvennye nauki, no. 2 (December 1, 2013): 22–27. http://dx.doi.org/10.15688/jvolsu11.2013.2.3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Isnenia, Isnenia. "Penggunaan Non-Steroid Antiinflamatory Drug dan Potensi Interaksi Obatnya Pada Pasien Muskuloskeletal." Pharmaceutical Journal of Indonesia 6, no. 1 (December 1, 2020): 47–55. http://dx.doi.org/10.21776/ub.pji.2020.006.01.8.

Full text

Abstract:

The main therapy on musculoskeletal patients is the use of non-steroidal anti-inflammatory drugs (NSAIDs) either as monotherapy or in combination with drugs of the same class or pain relievers from other groups. The use of more than one drugs have potentially caused drug-drug interactions that can affect to patient. This study was aimed to describe the patient's sociodemographic (sex, ages) and clinical (numbers of drugs, type of drugs and diagnose) characteristics, as well as to find the correlation between potential drug interactions with these variables. This research was a quantitative study with a cross sectional design. Data were taken from 100 medical records of patients who had diagnosed with top five musculoskeletal diseases. Data were analyzed descriptively for sex, ages, number of drugs, type of drugs, and potential drug interactions. Bivariate correlation with chi-square were conducted to find statistically significancy potential drug interactions with each variable consist of sex, ages, type of drugs and it’s diagnose. The result shows that the musculoskeletal patients were 44% male, 56% female. Most musculoskeletal patients were aged 18-65 years (78%). Patients who received drugs <5 were 68% and ≥ 5 were 32%. 54% of patients were taking the diclofenac and only 5% of patients were taking the two NSAIDs combination, diclofenac and ibuprofen. There was no significant correlation (p > 0,05) between potential drug interactions with age, sex, type of NSAID, and type of musculosceletal diseases.

APA, Harvard, Vancouver, ISO, and other styles

4

Renner, Rebecca. "Drams of Drugs and Dregs." Scientific American 286, no. 5 (May 2002): 29. http://dx.doi.org/10.1038/scientificamerican0502-29.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ismatov, Farrukh Asliddinovich. "DRUG TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS JAW ALVEOLITIS." Frontline Medical Sciences and Pharmaceutical Journal 02, no. 03 (March 1, 2022): 88–94. http://dx.doi.org/10.37547/medical-fmspj-02-03-09.

Full text

Abstract:

Non-steroidal anti-inflammatory drugs are widely used to suppress inflammation in the body. NSAIDs are available in different forms: tablets, capsules, ointments. They have three main properties: antipyretic, anti-inflammatory and analgesic. The best non-steroidal anti-inflammatory drug can only be chosen by a doctor, based on the individual characteristics of the patient. Self-treatment in this case may be fraught with serious adverse reactions or overdose. We suggest reading the list of drugs. The rating is based on value for money, patient feedback and expert opinion.

APA, Harvard, Vancouver, ISO, and other styles

6

A. Amer, Sayed. "المخدرات الجديدة: العقاقير المصممة." Security Policy Paper 2, no. 2 (December 31, 2021): 01–03. http://dx.doi.org/10.26735/ndan7653.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

D, Subba Reddy, Prasanthi G, Amruth Raj S, Hari Krishna T, Sowjanya K, and Shantha Kumari K. "EVALUATION OF ANTICANCER GENERIC DRUGS AND BRANDED DRUGS." Indian Research Journal of Pharmacy and Science 5, no. 1 (March 2018): 1378–91. http://dx.doi.org/10.21276/irjps.2018.5.1.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Khrypunova, Tetiana. "Relationships between the Ukrainian Public's Awareness of Psychotropic Drugs, Stigmatizing People Taking Psychotropic Drugs and Stopping Psychotropic Drug Medication without Consulting with a Doctor." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 6, no. 5 (October 27, 2021): 370–75. http://dx.doi.org/10.26693/jmbs06.05.370.

Full text

Abstract:

The purpose of the study was to outline possible relationships between public awareness of psychotropic drugs, stigmatization of people suffering from mental disorders and discontinuation of drugs without consultation with a doctor in Ukraine. Materials and methods. This study is based on the analysis of data obtained through an electronic questionnaire filled out by the Ukrainian public. Until April 2021 the questionnaire was freely available to everyone who wanted to take part in the survey. The questionnaire was distributed via an Internet link. Based on the obtained data, the respondents were divided into different categories depending on their education, profession (a medical worker was analyzed separately). Also, the respondents who had personal experience of using psychotropic drugs were interviewed especially deeply and in more details, depending on which group of drugs they used (antidepressants / antipsychotics / anxiolytics). The separate place in the study was given to identifying the general awareness of the Ukrainian public about correct and erroneous judgments about psychotropic drugs. Results and discussion. Based on the obtained data, main factors which are influencing people awareness of psychotropic drugs were identified, as well as the approximate percentage of citizens with erroneous judgments about psychotropic drugs. Thanks to the results of the questionnaire, the main possible reasons for the withdrawal of treatment with psychotropic drugs by patients without consultation with the attending physician were suggested (identified). Conclusion. It can be concluded from the obtained data that a person's awareness in the field of psychotropic drugs is most influenced by their own experience of their use. For this reason, the author would be interested to know how psychiatric patients are informed by their physicians. The author is aware that the amount of data obtained is not completely sufficient to create a significant picture of the general situation, but she hopes that the obtained data will still allow to get some idea of the situation as a whole. In conclusion, not only the obtained results in this study were outlined, but also possible further actions to obtain a more accurate picture of the situation were mentioned, and the topic of the next study was indicated in order to solve the identified problem

APA, Harvard, Vancouver, ISO, and other styles

9

Gillam, Tony. "Drugs or no drugs?" Nursing Standard 20, no. 23 (February 15, 2006): 26–27. http://dx.doi.org/10.7748/ns.20.23.26.s30.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Chawra, Himmat Singh, Y. S. Tanwar, Ritu M. Gilhotra, and S. K. Singh. "Gastroretentive drug delivery systems a potential approach for antihypertensive drugs: An updated review." Asian Pacific Journal of Health Sciences 5, no. 2 (June 2018): 217–23. http://dx.doi.org/10.21276/apjhs.2018.5.2.40.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Singh, Uday, Gurjeet Singh, and Randhir Singh. "A STUDY ON DRUG UTILIZATION PATTERN OF ANTIHYPERTENSIVE DRUGS IN TERTIARY CARE HOSPITAL." INDIAN RESEARCH JOURNAL OF PHARMACY AND SCIENCE 7, no. 2 (June 2020): 2184–93. http://dx.doi.org/10.21276/irjps.2020.7.2.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kaniwa, Masa-aki. "Drugs, Quasi-drugs and Cosmetics :." Material Cycles and Waste Management Research 25, no. 3 (May 31, 2014): 173–79. http://dx.doi.org/10.3985/mcwmr.25.173.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Frey, Bruno S. "Drugs: Drugs, economics and policy." Economic Policy 12, no. 25 (October 1997): 387–98. http://dx.doi.org/10.1111/1468-0327.00026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Frey, Bruno S. "Drugs: Drugs, economics and policy." Economic Policy 12, no. 25 (October 1997): 387–98. http://dx.doi.org/10.1111/1468-0327.t01-1-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Gao, Shan, Anoliefo Ijeoma Janefrancis, Qingwei Cui, Yuqian Mi, Zhou Tong, and Bingxue Yan. "RNAi drugs: Next generation drugs?" Chinese Science Bulletin 65, no. 7 (March 1, 2020): 540–46. http://dx.doi.org/10.1360/tb-2019-0211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Andersen, T. "Are newer drugs better drugs?" Obesity Reviews 4, no. 2 (May 2003): 75. http://dx.doi.org/10.1046/j.1467-789x.2003.00097.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Bateman, D. N., and S. Chaplin. "New Drugs: Centrally acting drugs." BMJ 296, no. 6619 (February 6, 1988): 417–19. http://dx.doi.org/10.1136/bmj.296.6619.417.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

., Nurhaedah, Santalia Banne Tondok, Juherah ., M. Ikbal Arif, Sulistyani Prabu Aji, Nurril Cholifatul Izza, Aminuddin ., et al. "My Drugs Your Drugs, Indonesia." International Journal of Membrane Science and Technology 10, no. 2 (June 21, 2023): 193–96. http://dx.doi.org/10.15379/ijmst.v10i2.1179.

Full text

Abstract:

Social Phenomena of Narcotics Circulation, especially Sidenreng Rappang Regency, has not shown maximum results, and even seems to be increasingly rampant to the remote villages. Sidenreng Rappang Regency, South Sulawesi Province, is known as the Lumbung Beras area, recently this positive stigma has shifted that Sidenreng Rappang Regency is now better known as the Narcotics Granary which is one of the drug trafficking centers in South Sulawesi. The results of the study obtained data, in 2015 with the number of 82 cases with 109 suspects, 2016 with 111 cases with 149 suspects, and 2017 with 140 cases with 197 suspects, and 2018 with 59 cases with the number of suspects 99 (Results of direct interviews with Sidrap Police Narcotics Officers and administrative staff, 31 July 2018). 1.Take strict action in accordance with the applicable law towards producers, distributors and users and carry out effective and educative coordination steps with related parties and the community. 2. Strive to increase the budget to rehabilitate victims of narcotics, psychotropic and other addictive substances.

APA, Harvard, Vancouver, ISO, and other styles

19

PALA, Elif, and Tuba DENKÇEKEN. "Integrating sub-pathway analysis to identify candidate drugs for COVID-19." International Journal of Medical Reviews and Case Reports 4, Reports in Neurology, Neurosur (2020): 71. http://dx.doi.org/10.5455/ijmrcr.covid-19-drugs.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Lee, Rensselaer W. "Drugs." Current History 95, no. 598 (February 1, 1996): 55–58. http://dx.doi.org/10.1525/curh.1996.95.598.55.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Jones, Jacquie. "Drugs." Callaloo 13, no. 2 (1990): 299. http://dx.doi.org/10.2307/2931703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Forrest, Jill. "Drugs . . ." Medical Journal of Australia 159, no. 5 (September 1993): 352. http://dx.doi.org/10.5694/j.1326-5377.1993.tb137879.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Izenman, Alan Julian. "Drugs." Statistical Science 16, no. 1 (February 2001): 35–57. http://dx.doi.org/10.1214/ss/998929475.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

&NA;. "DRUGS." Nursing 24, no. 12 (December 1994): 49–56. http://dx.doi.org/10.1097/00152193-199412000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Rushforth, Bruno. "Drugs." BMJ 328, Suppl S3 (March 1, 2004): 0403129. http://dx.doi.org/10.1136/sbmj.0403129.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Spillane, Joseph F. "Drugs." JAMA 289, no. 15 (April 16, 2003): 1997. http://dx.doi.org/10.1001/jama.289.15.1997-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Cerami, A., and K. S. Warren. "Drugs." Parasitology Today 10, no. 10 (January 1994): 404–6. http://dx.doi.org/10.1016/0169-4758(94)90234-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Small, Douglas. "Drugs." Victorian Literature and Culture 51, no. 3 (2023): 391–94. http://dx.doi.org/10.1017/s1060150323000165.

Full text

Abstract:

This “Keywords Redux” article examines the significance of drugs (psychoactive substances) in Victorian culture and literature, theorizing their potential for both performance enhancement and for pleasure.

APA, Harvard, Vancouver, ISO, and other styles

29

Jovicic, Jelena, Branka Gvozdic, Ljubisa Volas, Tatjana Brkic, Natasa Petrovic, and Nebojsa Ladjevic. "Old drugs are new again (drugs)." Serbian Journal of Anesthesia and Intensive Therapy 39, no. 5-6 (2017): 159–66. http://dx.doi.org/10.5937/sjait1706159j.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

O'connor, Louise, David Best, Rachel Best, and Jenny Rowley. "Missed Opportunities: Drugs and Drugs Education." Early Child Development and Care 141, no. 1 (January 1998): 73–109. http://dx.doi.org/10.1080/0300443981410106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Prinz, Aloys. "Drugs: Do European drugs policies matter?" Economic Policy 12, no. 25 (October 1997): 371–85. http://dx.doi.org/10.1111/1468-0327.00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Williams, Robert. "Discontinued drugs in 2007: oncology drugs." Expert Opinion on Investigational Drugs 17, no. 12 (November 3, 2008): 1791–816. http://dx.doi.org/10.1517/13543780802465737.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Xu-song, Zhang, and Xiang Bing-ren. "Discontinued drugs in 2007: cardiovascular drugs." Expert Opinion on Investigational Drugs 17, no. 12 (November 3, 2008): 1817–28. http://dx.doi.org/10.1517/13543780802465992.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Xu-song, Zhang, and Xiang Bing-ren. "Discontinued drugs in 2008: cardiovascular drugs." Expert Opinion on Investigational Drugs 18, no. 7 (June 24, 2009): 875–85. http://dx.doi.org/10.1517/13543780903020308.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Williams, Robert. "Discontinued drugs in 2008: oncology drugs." Expert Opinion on Investigational Drugs 18, no. 11 (August 11, 2009): 1581–94. http://dx.doi.org/10.1517/13543780903151806.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Suckling, Keith. "Discontinued drugs in 2005: cardiovascular drugs." Expert Opinion on Investigational Drugs 15, no. 11 (October 16, 2006): 1299–308. http://dx.doi.org/10.1517/13543784.15.11.1299.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kelland, Lloyd. "Discontinued drugs in 2005: oncology drugs." Expert Opinion on Investigational Drugs 15, no. 11 (October 16, 2006): 1309–18. http://dx.doi.org/10.1517/13543784.15.11.1309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Kerwin, Robert. "Discontinued drugs in 2005: schizophrenia drugs." Expert Opinion on Investigational Drugs 15, no. 12 (November 15, 2006): 1487–95. http://dx.doi.org/10.1517/13543784.15.12.1487.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Williams, Robert. "Discontinued drugs in 2006: oncology drugs." Expert Opinion on Investigational Drugs 17, no. 3 (March 2008): 269–83. http://dx.doi.org/10.1517/13543784.17.3.269.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Zhao, Hong-ping, Xu-song Zhang, and Bing-ren Xiang. "Discontinued drugs in 2010: cardiovascular drugs." Expert Opinion on Investigational Drugs 20, no. 10 (August 26, 2011): 1311–25. http://dx.doi.org/10.1517/13543784.2011.611500.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Williams, Robert. "Discontinued drugs in 2010: oncology drugs." Expert Opinion on Investigational Drugs 20, no. 11 (September 28, 2011): 1479–96. http://dx.doi.org/10.1517/13543784.2011.623697.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Chang, Sang G., and Puzant C. Torigian. "Expired Drugs are not Dead Drugs." American Journal of Health-System Pharmacy 50, no. 3 (March 1, 1993): 447–48. http://dx.doi.org/10.1093/ajhp/50.3.447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Zhao, Hong-Ping, Hong-Min Jiang, and Bing-Ren Xiang. "Discontinued drugs in 2011: cardiovascular drugs." Expert Opinion on Investigational Drugs 21, no. 10 (July 25, 2012): 1449–62. http://dx.doi.org/10.1517/13543784.2012.710198.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Williams, Robert. "Discontinued drugs in 2011: oncology drugs." Expert Opinion on Investigational Drugs 22, no. 1 (November 6, 2012): 9–34. http://dx.doi.org/10.1517/13543784.2013.739605.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Zhao, Hong-Ping, Hong-Min Jiang, and Bing-Ren Xiang. "Discontinued drugs in 2012: cardiovascular drugs." Expert Opinion on Investigational Drugs 22, no. 11 (August 30, 2013): 1437–51. http://dx.doi.org/10.1517/13543784.2013.832198.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Williams, Robert. "Discontinued drugs in 2012: oncology drugs." Expert Opinion on Investigational Drugs 22, no. 12 (October 8, 2013): 1627–44. http://dx.doi.org/10.1517/13543784.2013.847088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Cogen, Jonathan D., David P. Nichols, Christopher H. Goss, and Ranjani Somayaji. "Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway Infections." Journal of the Pediatric Infectious Diseases Society 11, Supplement_2 (September 1, 2022): S32—S39. http://dx.doi.org/10.1093/jpids/piac061.

Full text

Abstract:

Abstract Airway infections have remained a prominent feature in persons living with cystic fibrosis (CF) despite the dramatic improvements in survival in the past decades. Antimicrobials are a cornerstone of infection management for both acute and chronic maintenance indications. Historic clinical trials of antimicrobials in CF have led to the adoption of consensus guidelines for their use in clinical care. More recently, however, there are efforts to re-think the optimal use of antimicrobials for care with the advent of novel and highly effective CF transmembrane conductance regulator modulator therapies. Encouragingly, however, drug development has remained active concurrently in this space. Our review focuses on the evidence for and perspectives regarding antimicrobial use in both acute and maintenance settings in persons with CF. The therapeutic innovations in CF and how this may affect antimicrobial approaches are also discussed.

APA, Harvard, Vancouver, ISO, and other styles

48

Zaccara, Gaetano, and Emilio Perucca. "Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs." Epileptic Disorders 16, no. 4 (December 2014): 409–31. http://dx.doi.org/10.1684/epd.2014.0714.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Siegel, Miles G., and Michal Vieth. "Drugs in other drugs: a new look at drugs as fragments." Drug Discovery Today 12, no. 1-2 (January 2007): 71–79. http://dx.doi.org/10.1016/j.drudis.2006.11.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Suresh, Suresh, Pratiti Pratiti, Sunita Sunita, Sona Sona, Soni Soni, Tulika Tulika, and Mahalingam Mahalingam. "Over The Counter Drugs." Asian Pacific Journal of Health Sciences 1, no. 4 (October 2014): 365–69. http://dx.doi.org/10.21276/apjhs.2014.1.4.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!